Related Experiment Video

Updated: Aug 30, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Prospects for prevention and treatment of vascular cognitive impairment

Silvia Di Legge1, Vladimir Hachinski

  • 1Department of Clinical Neurological Sciences, London Health Sciences Centre, University of Western Ontario, 339 Windermere Road, N6A 5A5 London, Ontario, Canada. sdilegge@uwo.ca

Current Opinion in Investigational Drugs (London, England : 2000)
|October 30, 2003
PubMed

Insights

Vascular cognitive impairment (VCI) affects many due to aging and vascular disease. Early detection and intervention, aided by neuroimaging, are key to preventing dementia progression.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Gerontology

Background:

  • The aging population and increasing vascular disease rates elevate the risk of cognitive impairment.
  • Vascular cognitive impairment (VCI) is a significant consequence of vascular disease, impacting cognition.
  • Current dementia therapeutics show limited success, highlighting the need for preventative strategies.

Purpose of the Study:

  • To explore the role of vascular disease in cognitive impairment.
  • To identify imaging biomarkers for early VCI detection and intervention.
  • To emphasize the importance of early intervention and preventative therapeutics for VCI.

Main Methods:

  • Review of risk factors for stroke and their correlation with cognitive decline and Alzheimer's disease pathology.
  • Non-invasive magnetic resonance imaging (MRI) techniques to detect brain changes like infarcts, white matter lesions, and atrophy.
  • Integration of neuropsychological, neuroimaging, genetic, and pathological data to understand VCI pathophysiology.

Main Results:

  • Vascular risk factors are linked to brain changes, cognitive loss, and Alzheimer's pathology.
  • Imaging techniques can identify surrogate markers for dementia processes and intervention targets.
  • Early identification of at-risk patients via MRI can guide preventative strategies.

Conclusions:

  • VCI is a growing concern linked to vascular disease and aging.
  • Non-invasive imaging and risk factor control are crucial for preventing cognitive decline.
  • Understanding VCI pathophysiology may lead to early diagnostic criteria and novel treatments.

More Related Videos

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina07:32

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...